What is the address of Mat - Therapy?

The registered office of Mat - Therapy is located at Rue des Charrons, Neerh. 116, 1357 Hélécine.

Is Mat - Therapy still active?

Yes. According to the CBE (30 October 2026) Mat - Therapy is active, legal situation “Normale toestand”, started on 1 February 2021.

Is Mat - Therapy registered on Peppol?

Yes, Mat - Therapy is registered on the Peppol network with ID 0208:0762732477.

What is the enterprise number of Mat - Therapy?

The enterprise number of Mat - Therapy is BE0762732477.

When was Mat - Therapy founded?

Mat - Therapy was founded on 1 February 2021.

Who are the directors of Mat - Therapy?

According to the 2025 annual accounts, the directors of Mat - Therapy are: Mathieu Claes.

Is Mat - Therapy a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 February 2021; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Mat - Therapy make in 2025?

Mat - Therapy posted a profit after taxes of € 26,517 in financial year 2025.

What is the revenue of Mat - Therapy?

As a small company, Mat - Therapy is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 44,847.

Mat - Therapy (Private Limited) - Hélécine - BE0762732477

Dossier Mat - Therapy, printed on 30 October 2026 from databakkes.be/en/0762732477/mat-therapy. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Mat - Therapy from Hélécine, company number BE0762732477, closed financial year 2025 with a result of € 26,517 after tax. For that financial year Mat - Therapy recorded a gross margin of € 44,847 and equity of € 86,679. Compared with financial year 2024, the result moved from € 30,129 to € 26,517. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.

What it is worth Healthy

€ 86,679

▼ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 26,517

▼ 12% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 125,834

▲ 1% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 27,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 753

▼ 48% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,215

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 42,570 Gross margin 2022: € 42,570 First fiscal year in the series	€ 42,544 Gross margin 2023: € 42,544 Unchanged (€ 42,570) Unfavourable step	€ 54,235 Gross margin 2024: € 54,235 ▲ 27% vs 2023 (€ 42,544) Favourable step	€ 44,847 Gross margin 2025: € 44,847 ▼ 17% vs 2024 (€ 54,235) Unfavourable step	▼ 17%
Profit after taxes	€ 26,108 Profit after taxes 2022: € 26,108 First fiscal year in the series	€ 23,241 Profit after taxes 2023: € 23,241 ▼ 11% vs 2022 (€ 26,108) Unfavourable step	€ 30,129 Profit after taxes 2024: € 30,129 ▲ 30% vs 2023 (€ 23,241) Favourable step	€ 26,517 Profit after taxes 2025: € 26,517 ▼ 12% vs 2024 (€ 30,129) Unfavourable step	▼ 12%
Equity	€ 55,625 Equity 2022: € 55,625 First fiscal year in the series	€ 78,033 Equity 2023: € 78,033 ▲ 40% vs 2022 (€ 55,625) Favourable step	€ 87,163 Equity 2024: € 87,163 ▲ 12% vs 2023 (€ 78,033) Favourable step	€ 86,679 Equity 2025: € 86,679 ▼ 1% vs 2024 (€ 87,163) Unfavourable step	▼ 1%
Total debts	€ 52,434 Total debts 2022: € 52,434 First fiscal year in the series	€ 32,211 Total debts 2023: € 32,211 ▼ 39% vs 2022 (€ 52,434) Favourable step	€ 51,656 Total debts 2024: € 51,656 ▲ 60% vs 2023 (€ 32,211) Unfavourable step	€ 47,887 Total debts 2025: € 47,887 ▼ 7% vs 2024 (€ 51,656) Favourable step	▼ 7%
Cash	€ 75,012 Cash 2022: € 75,012 First fiscal year in the series	€ 89,605 Cash 2023: € 89,605 ▲ 19% vs 2022 (€ 75,012) Favourable step	€ 124,016 Cash 2024: € 124,016 ▲ 38% vs 2023 (€ 89,605) Favourable step	€ 125,834 Cash 2025: € 125,834 ▲ 1% vs 2024 (€ 124,016) Favourable step	▲ 1%
Retained profit	€ 50,625 Retained profit 2022: € 50,625 First fiscal year in the series	€ 73,033 Retained profit 2023: € 73,033 ▲ 44% vs 2022 (€ 50,625) Favourable step	€ 82,163 Retained profit 2024: € 82,163 ▲ 13% vs 2023 (€ 73,033) Favourable step	€ 81,679 Retained profit 2025: € 81,679 ▼ 1% vs 2024 (€ 82,163) Unfavourable step	▼ 1%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 833 Dividend 2023: € 833 ▲ 4% vs 2022 (€ 800) Unchanged	€ 21,000 Dividend 2024: € 21,000 ▲ € 20,167 vs 2023 (€ 833) Unchanged	€ 27,000 Dividend 2025: € 27,000 ▲ 29% vs 2024 (€ 21,000) Unchanged	▲ 29%
Bank debt	€ 23,203 Bank debt 2022: € 23,203 First fiscal year in the series	€ 15,248 Bank debt 2023: € 15,248 ▼ 34% vs 2022 (€ 23,203) Favourable step	€ 7,040 Bank debt 2024: € 7,040 ▼ 54% vs 2023 (€ 15,248) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 7,040) Favourable step	▼ 100%
Balance sheet total	€ 108,059 Balance sheet total 2022: € 108,059 First fiscal year in the series	€ 110,244 Balance sheet total 2023: € 110,244 ▲ 2% vs 2022 (€ 108,059) Unchanged	€ 138,819 Balance sheet total 2024: € 138,819 ▲ 26% vs 2023 (€ 110,244) Unchanged	€ 134,567 Balance sheet total 2025: € 134,567 ▼ 3% vs 2024 (€ 138,819) Unchanged	▼ 3%

Key figures of Mat - Therapy, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Mat - Therapy?

What happened at Mat - Therapy in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 25, 2026 New annual accounts for financial year 2025: profit of € 26,517 (▼ 12% vs 2024). Source: NBB ↗
Feb 1, 2021 New establishment in Hélécine. KBO
2021 Mathieu Claes became a director. NBB
Feb 1, 2021 Start of the company according to the CBE. KBO

In short

From € 26,108 profit in 2022 to € 26,517 profit in 2025.

Paid € 49,408 in corporate taxes since 2022.

Best year ever: 2024, with € 30,129 profit.

Paid out € 49,633 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Mathieu Claes

Mat - Therapy

Behind Mat - Therapy is Mathieu Claes.

Directors

According to the 2025 annual accounts

Mathieu Claes

Director

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Rue des Charrons, Neerh. 116

1357 Hélécine

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0762.732.477
VAT number: BE 0762.732.477
Registered office: Rue des Charrons, Neerh. 116, 1357 Hélécine
Names & denominations: Mat - Therapy
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 1 February 2021
Peppol: Active · Active since 16 Jan 2026
Contact: [email protected]

View on CBE Public ↗ Annual accounts (NBB) ↗